Cognizant has launched Patient Hub Operations, a service that pairs AI agents with healthcare specialists to handle the paperwork between a prescription and the start of therapy. Built on NVIDIA accelerated computing, it aims to cut that time from about 30 days to less than seven, a target based on Cognizant’s own analysis of current workflows and case volumes.
Quick Take
- The service: AI agents handle patient conversations and routine admin work, while Cognizant specialists review, approve or escalate AI-prepared actions in one dashboard.
- The goal: Prescription to therapy in under seven days instead of about 30, by running coverage checks, insurer approval and financial assistance in parallel.
- The agents at launch: Patient Inquiry, Intelligent Routing, Translation, Human Handoff and Call Summarization.
- The tech: NVIDIA NIM microservices for speech, NeMo Guardrails, and Nemotron language and speech models customised by Cognizant.
- Availability: Available now. Clients can host it in their own cloud and keep control of their data.
In plain English
Before many patients can start a new specialty drug, someone has to confirm insurance coverage, get the insurer’s approval and find financial help, often by phone, fax and email. Each step can add days. Cognizant’s system lets AI do the routine parts at the same time instead of one after another, while trained staff keep the final say.
What happened
Cognizant announced the offering on November 18. It works from each programme’s prescribing information, standard operating procedures and payer rules, and connects to the CRM, contact center and workflow systems clients already use. The dashboard links to Cognizant AI Nexus, the company’s multi-model operating layer launched in October.
“Cognizant Patient Hub Operations hands routine steps to AI agents and keeps experienced specialists in charge of the decisions that matter,” said Sandeep Bhasin, Global Head of Intuitive Operations and Automation at Cognizant.
“Working with Cognizant, we’re bringing NVIDIA accelerated computing to specialized language models and agents designed to streamline patient access workflows while keeping healthcare specialists in control of critical decisions,” said Alvin Dacosta, Vice President, Global Consulting at NVIDIA.
Background
Where programmes need clinical expertise, Cognizant says specialists can draw on its life sciences clinical staff of more than 5,000 pharmacists and doctors and more than 2,000 nurses. The service is designed to support HIPAA-aligned handling of patient information. Insurance and access work has become a key target for health AI agents, as with August AI’s agent that fights insurance denials.
Why it matters
Delays in getting approved therapies to patients are a real health problem, not just an admin nuisance. Pharma companies run large patient support hubs to manage them. If agents can cut weeks out of that process, patients start treatment sooner and drug makers can serve more patients without hiring at the same rate.
What’s still open
- Whether the under-seven-days target holds in live programmes.
- Which pharma companies are using the service.
- How errors by the agents are caught and audited.
About the analysis
Researched and written with AI assistance under the editorial responsibility of the i10X News team. The title image is an AI-generated image. Read our AI Use Policy. Spotted an error? Request a correction.
This independent i10x analysis is based on Cognizant’s press release. All quotes are taken from that source.
Sources (plain text, no links):
- Cognizant press release: “Introducing Cognizant Patient Hub Operations: AI-enabled patient access offering designed to shorten the path from prescription to therapy” (November 18, 2026)
i10x Perspective
The fastest health gains from AI may come from the least glamorous places, like fax queues and insurance forms. Patient access is a measurable, rule-heavy process where agents fit well. More on our Health & Medical Research page.






